Analyses of NY-ESO-1-specific spontaneous immune responses in cancer patients revealed
that antibody and both CD4+ and CD8+ T cell responses were induced together in cancer …

Introduction: Breast cancer is the most common cancer as well as the first cause of death by
cancer in women worldwide. Although routine treatment improves the outcome of early …

Introduction 3. DC Immunobiology 4. Dendritic Cell Subpopulations 5. The type1/type 2
dualism and cancer 6. Generation of DC for Therapy 7. Consideration of DC Maturation …

Vaccines utilizing cytotoxic T lymphocyte (CTL) epitopes are promising for the treatment of
cancer and chronic infectious diseases. Tumor-associated antigen L6 (TAL6) is …

Purpose The authors present a protocol for the in vivo evaluation, using different imaging
techniques, of lymph node (LN) homing of tumor-specific dendritic cells (DCs) in a murine …

Previous studies have shown that mRNA-electroporated dendritic cells (DCs) are able to
process and present tumor-associated antigens, leading to the activation of tumor-specific T …

Dendritic cells (DC) are key players in several types of cancer vaccines. Large numbers of
DC can easily be generated in closed systems from the monocyte fraction of the peripheral …

There has been a surge of interest in the use of dendritic cell (DC) vaccination as cellular
immunotherapy for numerous cancers. Despite some encouraging results, this therapeutic …

Выяснение механизмов врожденного иммунитета, отвечающих за защиту от
возникновения злокачественных опухолей, способствует разработке новых подходов к …

Anticancer immunotherapy using dendritic cell (DC) based vaccines provides an adjuvant
therapeutic strategy that is not cross reactive with conventional therapeutics. However …